Zobrazeno 1 - 5
of 5
pro vyhledávání: '"María Victoria Villacañas Palomares"'
Autor:
María Ochagavía Sufrategui, María Ángeles Gil Lemus, Lucrecia Yáñez San Segundo, Carlos Antonio Amado Diago, Sara Barbadillo Villanueva, Virginia Martínez Callejo, María Victoria Villacañas Palomares, Marta Valero Domínguez
Publikováno v:
Farmacia Hospitalaria. 47:T69-T74
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba1debc575c3eb531c142b9b851934a0
https://doi.org/10.1016/j.farma.2022.12.010
https://doi.org/10.1016/j.farma.2022.12.010
Autor:
María Ochagavía Sufrategui, María Ángeles Gil Lemus, Lucrecia Yáñez San Segundo, Carlos Antonio Amado Diago, Sara Barbadillo Villanueva, Virginia Martínez Callejo, María Victoria Villacañas Palomares, Marta Valero Domínguez
Publikováno v:
Farmacia Hospitalaria. 47:69-74
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c721dac7b33ac6a4a4db81c58621d34
https://doi.org/10.1016/j.farma.2022.11.006
https://doi.org/10.1016/j.farma.2022.11.006
Autor:
María, Ochagavía Sufrategui, María Ángeles, Gil Lemus, Lucrecia, Yáñez San Segundo, Carlos Antonio, Amado Diago, Sara, Barbadillo Villanueva, Virginia, Martínez Callejo, María Victoria, Villacañas Palomares, Marta, Valero Domínguez
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.
To evaluate adherence and quality of life to oral antineoplastic treatment in patients with chronic lymphocytic leukemia. To compare adherence and QoL according to treatment subgroups and treatment-line subgroups.We conducted a descriptive prospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b1c3e492f806b96a0dc3918be4b1d76a
https://pubmed.ncbi.nlm.nih.gov/36599751
https://pubmed.ncbi.nlm.nih.gov/36599751
Autor:
Carmen María Valencia Soto, Virginia Martínez Callejo, Adela García-Avello Fernández-Cueto, María Victoria Villacañas Palomares, Sara Barbadillo Villanueva, María Ochagavía Sufrategui, Marta Francisca López-Brea Piqueras, Marta Valero Domínguez
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311731
Introduction Capmatinib is a mesenchymal-epithelial transition (MET) inhibitor authorized for metastatic non-small cell lung cancer (NSCLC) with MET exon 14 skipping mutation treatment in adult patients. Case report We report a case of an elderly fem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef1320b9759e34ff9c43138d68a3f93a
https://doi.org/10.1177/10781552231173120
https://doi.org/10.1177/10781552231173120
Autor:
Valencia Soto, Carmen María, Martínez Callejo, Virginia, García-Avello Fernández-Cueto, Adela, Villacañas Palomares, María Victoria, Barbadillo Villanueva, Sara, Ochagavía Sufrategui, María, López-Brea Piqueras, Marta Francisca, Valero Domínguez, Marta
Publikováno v:
Journal of Oncology Pharmacy Practice; Sep2023, Vol. 29 Issue 6, p1484-1488, 5p